Researchers who meet pre-specified requirements can request clinical trial information from studies sponsored by Bristol-Myers Squibb and obtain an independent scientific review from DCRI, according to the news release.
Clinical trial information such as protocols, full clinical study reports and anonymous patient-level data will be made available.
“Bristol-Myers Squibb’s collaboration with DCRI reflects our commitment to providing broader, more timely access to important clinical trial information and serves as a catalyst to strengthening public confidence in medicines, advancing science and improving public health,” said Francis Cuss, MB BChir, executive vice president and chief scientific officer of Bristol-Myers Squibb, in the news release.
More Articles on Clinical Trials:
BBK Worldwide Unveils 2 New Apps for Clinical Trial Patient Engagement
Inside the One C. Diff Vaccine Focusing on Prevention, Not Treatment
6 Companies Developing C. Diff Solutions
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.